A phase 11 study of regional 2mweekly 5mfluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases
1997

Intra-arterial 5-FU for Colorectal Liver Metastases

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): JD Howell, CS McArdle, DJ Kerr, J Buckles, JA Ledermann, I Taylor, HJ Gallagher, J Budden

Hypothesis

Intra-arterial treatment is associated with higher response rates and possibly prolonged survival compared with systemic therapy.

Conclusion

The study found a 46% overall response rate with a median survival of 19 months for patients treated with intra-arterial 5-FU.

Supporting Evidence

  • Overall response rate was 46% with 8% complete response.
  • Median follow-up was 17 months.
  • Median survival was estimated at 19 months.
  • Eight patients experienced grade 3 or 4 toxicity.

Takeaway

Doctors gave a special medicine directly to the liver to help people with cancer, and many of them got better for a while.

Methodology

Patients received intra-arterial 5-FU and folinic acid, with treatment cycles repeated every two weeks, and responses assessed after six treatments.

Potential Biases

Potential bias due to lack of randomization and the observational nature of the study.

Limitations

The study had a small sample size and was not randomized against a control group.

Participant Demographics

42 patients (17 female, 25 male) with a median age of 60 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication